About MPD-RC
The Myeloproliferative Disorders Research Consortium (MPD-RC) is an international, multi-institutional non profit consortium funded by the National Cancer Institute and set up to coordinate, facilitate, and perform basic and clinical research investigating the genetic and cellular mechanisms of the Philadelphia Chromosome (Ph) negative myelo-proliferative disorders (MPD).
The ultimate goal is to develop novel therapeutic strategies to improve the management of patients with this type of diseases. More »
Info for Patients
Find out more about Myeloproliferative Disorders, their symptoms, diagnosis and treatment. More »
Find patient support group and share your experience with other patients and their family. More »
Find patient support group and share your experience with other patients and their family. More »
New Trial: MPD-111
We are about to start enrolling patients in the study 111.
»111 Protocol on ClinicalTrials.gov
MPD-112
We are now recruiting patients also for the clinical trial 112.
»112 Protocol on ClinicalTrials.govActive Trials
We are now recruiting for trials 104, 105, 106, and 107.